US2008185313A1PendingUtilityA1

Medicament regimen for treating bronchitis or lower respiratory tract condition

24
Individually held — no corporate assignee on recordPriority: Feb 5, 2007Filed: Feb 5, 2007Published: Aug 7, 2008
Est. expiryFeb 5, 2027(~0.5 yrs left)· nominal 20-yr term from priority
Inventors:Donna F. White
A61J 7/04
24
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A therapeutic treatment regimen for a bronchitic condition or lower respiratory tract infection and method of treating same a subject in need thereof are described. The regimen comprises at least one dosage of an oral antibiotic, at least one therapeutically effective dosage of an oral adjunct medication selected from antitussives, expectorants, antihistamines, decongestants, anticholinergics, mucolytics and combinations thereof and a prepackaged dosage dispenser comprising the oral antibiotic and the oral adjunct medication. The method comprises providing a prepackaged dosage dispenser comprising an oral antibiotic and an oral adjunct medication, providing administering indicia integrated into the prepackaged dosage dispenser for administration of the oral antibiotic and oral adjunct medication.

Claims

exact text as granted — not AI-modified
1 . A method of providing a treatment regimen for treating a bronchitic condition in a subject in need thereof, the method comprising:
 (a) providing a prepackaged dosage dispenser comprising an oral antibiotic effective for treating the bronchitic condition and a oral adjunct medication selected from antitussives, expectorants, antihistamines, decongestants, anticholinergics, mucolytics and combinations thereof; and   (b)providing administering indicia for administering the oral antibiotic and the oral adjunct medication for treating the bronchitic condition, the indicia being integrated with the prepackaged dosage dispenser.   
   
   
       2 . The method of  claim 1 , wherein the bronchitic condition is an acute bacterial exacerbation related to chronic bronchitis. 
   
   
       3 . The method of  claim 1 , wherein the bronchitic condition is a secondary bacterial exacerbation related to acute bronchitis. 
   
   
       4 . The method of  claim 1 , wherein the treatment regimen provides for improved therapeutic compliance. 
   
   
       5 . The method of  claim 1 , wherein the treatment regimen provides for reduced medication error. 
   
   
       6 . The method of  claim 1 , wherein the at least one oral antibiotic is selected from the class of antibiotics consisting of penicillins, cephalosporins and macrolides. 
   
   
       7 . The method of  claim 1 , wherein the at least one oral antibiotic is selected from the group consisting of amoxicillin, azithromycin, cefdinir, cefditoren, cefprozil, cefuroxime and clarithromycin. 
   
   
       8 . The method of  claim 1 , wherein the at least one oral adjunct medication is selected from the group consisting of benzonatate, carbetapentane, chlorpheniramine, dextromethorphan, guaifenesin, hydrocodone, methscopolamine, phenylephrine and pseudoephedrine. 
   
   
       9 . The method of  claim 1 , wherein the at least one oral adjunct medication is a decongestant. 
   
   
       10 . The method of  claim 9 , wherein the decongestant is phenylephrine, phenylpropanolamine or pseudoephedrine. 
   
   
       11 . The method of  claim 1 , wherein the at least one oral antibiotic is selected from the group consisting of amoxicillin, azithromycin, cefdinir, cefditoren, cefprozil, cefuroxime and clarithromycin; and the at least one oral adjunct medication is phenylephrine or pseudoephedrine. 
   
   
       12 . The method of  claim 1 , wherein the oral antibiotic comprises amoxicillin/clavulanate and the oral adjunct medication comprises phenylephrine and guaifenesin. 
   
   
       13 . The method of  claim 1 , wherein the oral antibiotic comprises amoxicillin/clavulanate and the oral adjunct medication comprises pseudoephedrine. 
   
   
       14 . The method of  claim 1 , wherein the oral antibiotic comprises azithromycin and the oral adjunct medication comprises pseudoephedrine, guaifenesin and dextromethorphan. 
   
   
       15 . The method of  claim 1 , wherein the oral antibiotic comprises azithromycin and the oral adjunct medication comprises chlorpheniramine and hydrocodone. 
   
   
       16 . The method of  claim 1 , wherein the oral antibiotic comprises cefdinir and the oral adjunct medication comprises pseudoephedrine, methscopolamine and chlorpheniramine. 
   
   
       17 . The method of  claim 1 , wherein the oral antibiotic comprises cefdinir and the oral adjunct medication comprises chlorpheniramine and hydrocodone. 
   
   
       18 . The method of  claim 1 , wherein the oral antibiotic comprises cefdinir and the oral adjunct medication comprises dextromethorphan and guaifenesin. 
   
   
       19 . The method of  claim 1 , wherein the oral antibiotic comprises cefditoren and the oral adjunct medication comprises carbetapentane and pseudoephedrine. 
   
   
       20 . The method of  claim 1 , wherein the oral antibiotic comprises cefditoren and the oral adjunct medication comprises carbetapentane, guaifenesin, phenylephrine, and hydrocodone. 
   
   
       21 . The method of  claim 1 , wherein the oral antibiotic comprises cefditoren and the oral adjunct medication comprises benzonatate. 
   
   
       22 . The method of  claim 1 , wherein the oral antibiotic comprises cefditoren and the oral adjunct medication comprises carbetapentane, guaifenesin and phenyephrine. 
   
   
       23 . The method of  claim 1 , wherein the oral antibiotic comprises cefprozil and the oral adjunct medication comprises benzonatate. 
   
   
       24 . The method of  claim 1 , wherein the oral antibiotic comprises cefuroxime axetil and the oral adjunct medication comprises chlorpheniramine and hydrocodone. 
   
   
       25 . The method of  claim 1 , wherein the oral antibiotic comprises clarithromycin and the oral adjunct medication comprises pseudoephedrine, hydrocodone and guaifenesin. 
   
   
       26 . A method of providing a treatment regimen for a lower respiratory tract infection condition in a subject in need thereof, the method comprising:
 (a) providing a prepackaged dosage dispenser comprising an oral antibiotic effective for treating a bacterial infection related to a lower respiratory tract infection condition and a oral adjunct medication selected from antitussives, expectorants, antihistamines, decongestants, anticholinergics, mucolytics and combinations thereof; and   (b) providing administering indicia for administering the oral antibiotic and the oral adjunct medication for treating a lower respiratory tract infection condition, the indicia being integrated with the prepackaged dosage dispenser.   
   
   
       27 . The method of treating bronchitis of  claim 26 , wherein the treatment regimen provides for improved therapeutic compliance. 
   
   
       28 . The method of treating bronchitis of  claim 26 , wherein the treatment regimen provides for reduced medication error. 
   
   
       29 . The method of  claim 26 , wherein the at least one oral antibiotic is selected from the class of antibiotics consisting of penicillins, cephalosporins and macrolides. 
   
   
       30 . The method of  claim 26 , wherein the at least one oral antibiotic is selected from the group consisting of amoxicillin, azithromycin, cefdinir, cefditoren, cefprozil, cefuroxime and clarithromycin. 
   
   
       31 . The method of  claim 26 , wherein the at least one oral adjunct medication is selected from the group consisting of benzonatate, carbetapentane, chlorpheniramine, dextromethorphan, guaifenesin, hydrocodone, methscopolamine, phenylephrine and pseudoephedrine. 
   
   
       32 . The method of  claim 26 , wherein the at least one oral adjunct medication is an decongestant. 
   
   
       33 . The method of  claim 26 , wherein the decongestant is phenylephrine, phenylpropanolamine or pseudoephedrine. 
   
   
       34 . The method of  claim 26 , wherein the at least one oral antibiotic is selected from the group consisting of amoxicillin, azithromycin, cefdinir, cefditoren, cefprozil, cefuroxime and clarithromycin; and the at least one oral adjunct medication is phenylephrine or pseudoephedrine. 
   
   
       35 . The method of  claim 26 , wherein the oral antibiotic comprises amoxicillin/clavulanate and the oral adjunct medication comprises phenylephrine and guaifenesin. 
   
   
       36 . The method of  claim 26 , wherein the oral antibiotic comprises amoxicillin/clavulanate and the oral adjunct medication comprises pseudoephedrine. 
   
   
       37 . The method of  claim 26 , wherein the oral antibiotic comprises azithromycin and the oral adjunct medication comprises pseudoephedrine, guaifenesin and dextromethorphan. 
   
   
       38 . The method of  claim 26 , wherein the oral antibiotic comprises azithromycin and the oral adjunct medication comprises chlorpheniramine and hydrocodone. 
   
   
       39 . The method of  claim 26 , wherein the oral antibiotic comprises cefdinir and the oral adjunct medication comprises pseudoephedrine, methscopolamine and chlorpheniramine. 
   
   
       40 . The method of  claim 26 , wherein the oral antibiotic comprises cefdinir and the oral adjunct medication comprises chlorpheniramine and hydrocodone. 
   
   
       41 . The method of  claim 26 , wherein the oral antibiotic comprises cefdinir and the oral adjunct medication comprises dextromethorphan and guaifenesin. 
   
   
       42 . The method of  claim 26 , wherein the oral antibiotic comprises cefditoren and the oral adjunct medication comprises carbetapentane and pseudoephedrine. 
   
   
       43 . The method of  claim 26 , wherein the oral antibiotic comprises cefditoren and the oral adjunct medication comprises carbetapentane, guaifenesin, phenylephrine, and hydrocodone. 
   
   
       44 . The method of  claim 26 , wherein the oral antibiotic comprises cefditoren and the oral adjunct medication comprises benzonatate. 
   
   
       45 . The method of  claim 26 , wherein the oral antibiotic comprises cefditoren and the oral adjunct medication comprises carbetapentane, guaifenesin and phenyephrine. 
   
   
       46 . The method of  claim 26 , wherein the oral antibiotic comprises cefprozil and the oral adjunct medication comprises benzonatate. 
   
   
       47 . The method of  claim 26 , wherein the oral antibiotic comprises cefuroxime axetil and the oral adjunct medication comprises chlorpheniramine and hydrocodone. 
   
   
       48 . The method of  claim 26 , wherein the oral antibiotic comprises clarithromycin and the oral adjunct medication comprises pseudoephedrine, hydrocodone and guaifenesin.

Join the waitlist — get patent alerts

Track US2008185313A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.